Blood · 2006 · 135 citations · 40 references
MedicineMolecular GeneticsOncologyCancer GeneticsMolecular OncologyNeoplasiaCancer CytogeneticsCancer GenomicsLymphoid NeoplasmsLymphoid TumorsOncogene MutationsBrca MutationsBrca2 DeficiencyBrca2 InactivationBrca2 Mutation Risk
We conducted a large-scale association study to identify low-penetrance susceptibility alleles for chronic lymphocytic leukemia (CLL), analyzing 992 patients and 2707 healthy controls. To increase the likelihood of identifying disease-causing alleles we genotyped 1467 coding nonsynonymous single nucleotide polymorphisms (nsSNPs) in 865 candidate cancer genes, biasing nsSNP selection toward those predicted to be deleterious. Preeminent associations were identified in SNPs mapping to genes pivotal in the DNA damage-response and cell-cycle pathways, including ATM F858L (odds ratio [OR] = 2.28, P < .0001) and P1054R (OR = 1.68, P = .0006), CHEK2 I157T (OR = 14.83, P = .0008), BRCA2 N372H (OR = 1.45, P = .0032), and BUB1B Q349R (OR = 1.42, P = .0038). Our findings implicate variants in the ATM-BRCA2-CHEK2 DNA damage-response axis with risk of CLL.
40
Gene Ontology: tool for the unification of biology
Michael Ashburner, Catherine A. Ball, Judith A. Blake et al. · Nature Genetics · 2000 · 44.6K citations · Full text
The Future of Genetic Studies of Complex Human Diseases
Neil Risch, Kathleen R. Merikangas · Science · 1996 · 5.4K citations
The KEGG resource for deciphering the genome
M. Kanehisa · Nucleic Acids Research · 2003 · 5.3K citations · Full text
Empirical threshold values for quantitative trait mapping.
Gary A. Churchill, R. W. Doerge · Genetics · 1994 · 5K citations · Full text